Pharmacological profile of the clonidine-induced inhibition of vasodepressor sensory outflow in pithed rats: Correlation with a2A/2C-adrenoceptors (British Journal of Pharmacology (2008) 154 (51-59) DOI: 10.1038/bjp.2008.49);Pharmacological profile of the clonidine-induced inhibition of vasodepressor sensory outflow in pithed rats: Correlation with α2A/2C-adrenoceptors

British Journal of Pharmacology

Volumn 154, Issue 1, 2008, Pages 51-59

  Villalon C M ^a,c   Albarran Juarez J A ^a   Lozano Cuenca, J ^a   Pertz, H H ^b   Gornemann T ^b   Centurion D ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c CINVESTAV COAPA   (Mexico)

Author keywords

BRL44408; Imiloxan; MK912; Pithed rat; Sensory nerves; Vasodilatation; CGRP

Indexed keywords

1,3,4,5',6,6',7,12B OCTAHYDRO 1',3' DIMETHYL 2H SPIRO[BENZO[B]FURO[2,3 A]QUINOLIZINE 2,4' PYRIMIDINE] 2' ONE; 2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; ALPHA CALCITONIN GENE RELATED PEPTIDE; CLONIDINE; HEXAMETHONIUM; IMILOXAN; METHOXAMINE; NORADRENALIN; RAUWOLSCINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG MECHANISM; ELECTROSTIMULATION; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; SENSORY NERVE; SPINAL ANIMAL; SPINAL CORD; SYMPATHETIC NERVE; WISTAR RAT;

EID: 42949171893     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.250     Document Type: Erratum

References (36)

1. Albarrán‐Juárez JA, Lozano‐Cuenca J, Monroy‐Ordoñez EB, Cobos‐Puc LE, Sánchez‐López A, Centurión D et al. (2006). Modulation of the nonadrenergic noncholinergic vasodepressor responses by alpha2‐adrenoceptors in pithed rats. Acta Pharmacol Sin 27: 155.
2. Alexander SPH, Mathie A, Peters JA (2007). Guide to receptors and channels (GRAC). 2nd edition (2007 revision). Br J Pharmacol 150 (Suppl 1): S11.
3. Boehm S, Kubista H (2002). Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacol Rev 54: 43–99.
4. Bulloch JM, Docherty JR, Flavahan NA, McGrath JC, McKean CE (1987). Difference in the potency of alpha 2‐adrenoceptor agonists and antagonists between the pithed rabbit and rat. Br J Pharmacol 91: 457–466.
5. Buxton ILO (2006). Pharmacokinetics and pharmacodynamics: the dynamics of drugs absorption, distribution, action, and elimination. In: Brunton LL, Lazo JS, Parker KL, Goodman Gilman A (eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics, (11th Edition) McGraw‐Hill: New York. pp. 1–39.
6. Bylund DB (1992). Subtypes of alpha 1‐ and alpha 2‐adrenergic receptors. FASEB J 6: 832–839.
7. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP et al. (1994). International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46: 121–136.
8. Cobos‐Puc LE, Villalón CM, Sánchez‐López A, Lozano‐Cuenca J, Pertz HH, Gornemann T et al. (2007). Pharmacological evidence that alpha 2A‐ and alpha 2C‐adrenoceptors mediate the inhibition of cardioaccelerator sympathetic outflow in pithed rats. Eur J Pharmacol 554: 205–211.
9. Decker N, Ehrhardt JD, Leclerc G, Schwartz J (1984). Postjunctional alpha‐adrenoceptors. Alpha 1 and alpha 2 subtypes in rat vasculature in vitro and in vivo. Naunyn-Schmiedebergs Arch Pharmacol 326: 1–6.
10. Devedjian JC, Esclapez F, Denis‐Pouxviel C, Paris H (1994). Further characterization of human alpha 2‐adrenoceptor subtypes: [3H]RX821002 binding and definition of additional selective drugs. Eur J Pharmacol 252: 43–49.
11. Docherty JR (1998). Subtypes of functional alpha1‐ and alpha2‐adrenoceptors. Eur J Pharmacol 361: 1–15.
12. Eglen RM, Hudson AL, Kendall DA, Nutt DJ, Morgan NG, Wilson VG et al. (1998). Seeing through a glass darkly’: casting light on imidazoline ‘I’ sites. Trends Pharmacol Sci 19: 381–390.
13. Gavin T, Docherty JR (1996). Investigation of the subtype of α 2 ‐adrenoceptor mediating pressor responses in the pithed rat. Eur J Pharmacol 318: 81–87.
14. Gillespie JS, MacLaren A, Pollock D (1970). A method of stimulating different segments of the autonomic outflow from the spinal column to various organs in the pithed cat and rat. Br J Pharmacol 40: 257–267.
15. Göthert M, Bruss M, Bonisch H, Molderings GJ (1999). Presynaptic imidazoline receptors. New developments in characterization and classification. Ann N Y Acad Sci 881: 171–184.
16. Hein L, Altman JD, Kobilka BK (1999). Two functionally distinct alpha2‐adrenergic receptors regulate sympathetic neurotransmission. Nature 402: 181–184.
17. Hoffman BB (2001). Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, Goodman Gilman A (eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics, (10th edn.) McGraw‐Hill: New York. pp. 215–268.
18. Jasper JR, Lesnick JD, Chang LK, Yamanishi SS, Chang TK, Hsu SA et al. (1998). Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist‐mediated [35S]GTPgammaS binding. Biochem Pharmacol 55: 1035–1043.
19. Julius D, Basbaum AI (2001). Molecular mechanisms of nociception. Nature 413: 203–210.
20. Kawasaki H, Takasaki K, Saito A, Goto K (1988). Calcitonin gene‐related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature 335: 164–167.
21. Kawasaki H, Nuki C, Saito A, Takasaki K (1990). Adrenergic modulation of calcitonin gene‐related peptide (CGRP)‐containing nerve‐mediated vasodilation in the rat mesenteric resistance vessel. Brain Res 506: 287–290.
22. Kleinman L, Radford E (1964). Ventilation standards for small mammals. J Appl Physiol 19: 360–362.
23. Kobinger W, Pichler L (1978). Differentiation of drugs acting centrally upon the cardiovascular system by means of sympathetic and vagal responses. Clin Exp Hypertens 1: 229–249.
24. Richer C, Lefevre‐Borg F, Lechaire J, Gomeni C, Gomeni R, Giudicelli JF et al. (1987). Systemic and regional hemodynamic characterization of alpha‐1 and alpha‐2 adrenoceptor agonists in pithed rats. J Pharmacol Exp Ther 240: 944–953.
25. Shi TS, Winzer‐Serhan U, Leslie F, Hokfelt T (2000). Distribution and regulation of alpha(2)‐adrenoceptors in rat dorsal root ganglia. Pain 84: 319–330.
26. Steel RGD, Torrie JH (1980). Principles and Procedures of Statistics: A Biomedical Approach, 2nd edn. Tokyo: McGraw‐Hill Kogakusha.
27. Stone LS, Broberger C, Vulchanova L, Wilcox GL, Hokfelt T, Riedl MS et al. (1998). Differential distribution of alpha2A and alpha2C adrenergic receptor immunoreactivity in the rat spinal cord. J Neurosci 18: 5928–5937.
28. Sánchez‐López A, Centurión D, Vázquez E, Arulmani U, Saxena PR, Villalón CM (2003). Pharmacological profile of the 5‐HT‐induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5‐HT 1 and putative 5‐ht 5A/5B receptors. Br J Pharmacol 140: 725–735.
29. Taguchi T, Kawasaki H, Imamura T, Takasaki K (1992). Endogenous calcitonin gene‐related peptide mediates nonadrenergic noncholinergic depressor response to spinal cord stimulation in the pithed rat. Circ Res 71: 357–364.
30. Takeda M, Ikeda M, Tanimoto T, Lipski J, Matsumoto S (2002). Changes of the excitability of rat trigeminal root ganglion neurons evoked by alpha(2)‐adrenoreceptors. Neuroscience 115: 731–741.
31. Timmermans PB, Van Zwieten PA (1980). Vasoconstriction mediated by postsynaptic alpha 2‐adrenoceptor stimulation. Naunyn Schmiedebergs Arch Pharmacol 313: 17–20.
32. Uhlén S, Porter AC, Neubig RR (1994). The novel alpha‐2 adrenergic radioligand [3H]‐MK912 is alpha‐2C selective among human alpha‐2A, alpha‐2B and alpha‐2C adrenoceptors. J Pharmacol Exp Ther 271: 1558–1565.
33. Van Rossum D, Hanisch UK, Quirion R (1997). Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Biobehav Rev 21: 649–678.
34. Velasco M, Luchsinger A (1995). Central acting antihypertensive drugs: past, present and future. Am J Ther 2: 255–257.
35. Villalón CM, Centurión D, Rabelo G, De Vries P, Saxena PR, Sánchez‐López A (1998). The 5‐HT 1 ‐like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5‐HT 1A, 5‐HT 1B and 5‐HT 1D subtypes. Br J Pharmacol 124: 1001–1011.
36. Willems EW, Valdivia LF, Saxena PR, Villalón CM (2001). The role of several α 1 ‐ and α 2 ‐adrenoceptor subtypes mediating vasoconstriction in the canine external carotid circulation. Br J Pharmacol 132: 1292–1298.